Dexcom (DXCM) Operating Margin (2010 - 2026)

Dexcom (DXCM) has 17 years of Operating Margin data on file, last reported at 21.42% in Q1 2026.

• On a quarterly basis, Operating Margin rose 851.0% year-over-year to 21.42% in Q1 2026; TTM through Mar 2026 was 21.45%, a 620.0% increase from a year earlier, with the FY2025 full-year figure at 19.56%, up 468.0% from the prior year.
• Operating Margin for Q1 2026 stood at 21.42%, down from 25.64% in the prior quarter.
• Over the last five years, Operating Margin for DXCM reached as high as 25.64% in Q4 2025 and fell as low as 6.37% in Q1 2023.
• Historically, Operating Margin has averaged 16.04% across 5 years, with a median of 15.73% in 2024.
• On a YoY basis, Operating Margin climbed as much as 1530 bps in 2022 and fell as far as 591 bps in 2022.
• Year by year, Operating Margin stood at 15.38% in 2022, then surged by 36 bps to 20.97% in 2023, then retreated by 19 bps to 16.96% in 2024, then surged by 51 bps to 25.64% in 2025, then fell by 16 bps to 21.42% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 21.42% in Q1 2026, 25.64% in Q4 2025, and 20.05% in Q3 2025.